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Abstract
This paper presents the first findings of an integrative data analysis of individual level data from 
19 adolescent depression prevention trials (n=5210) involving 9 distinct interventions across two 
years post randomization. In separate papers, several interventions have been found to decrease the 
risk of depressive disorders or elevated depressive/internalizing symptoms among youth. One type 
of intervention specifically targets youth without a depressive disorder who are at risk due to 
elevated depressive symptoms and/or having a parent with a depressive disorder. A second type of 
intervention targets two broad domains: prevention of problem behaviors, which we define as drug 
use/abuse, sexual risk behaviors, conduct disorder or other externalizing problems, and general 
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mental health. Most of these latter interventions improve parenting or family factors. We examined 
the shared and unique effects of these interventions by level of baseline youth depressive 
symptoms, socio-demographic characteristics of the youth (age, sex, parent education and family 
income), type of intervention, and mode of intervention delivery to the youth, parent(s), or both. 
We harmonized 8 different measures of depression utilized across these trials and used growth 
models to evaluate intervention impact over two years. We found a significant overall effect of 
these interventions on reducing depressive symptoms over two years, and a stronger impact among 
those interventions that targeted depression specifically rather than problem behaviors or general 
mental health, especially when baseline symptoms were high. Implications for improving 
population-level impact are discussed.
Introduction
The prevention of depressive disorders and subclinical depressive symptoms is an important 
public health priority (Bertha & Balázs, 2013; Institute of Medicine & National Research 
Council, 2009; Munoz, Beardslee, & Leykin, 2012; Wesselhoeft, Sørensen, Heiervang, & 
Bilenberg, 2013). Research reviews and meta-analyses of trials testing existing interventions 
for youth suggest that depressive symptoms can be reduced and depressive disorders 
prevented, at least in the short-term (Horowitz & Garber, 2006; Institute of Medicine & 
National Research Council, 2009; Merry et al., 2011; Munoz et al., 2012; Stice, Shaw, 
Bohon, Marti, & Rohde, 2009). Yet, these interventions vary greatly in terms of the form of 
intervention they employ, the types of youth they target, and the putative mechanisms 
through which these interventions are hypothesized to work. A recent overview of meta-
analyses for depression concluded there was modest preventive impact of interventions for 
depression in youth with significant heterogeneity across trials (Sandler et al., 2014), 
although relatively little information is available to account for such variation in impact. For 
preventive interventions to be maximally effective it is important to understand “for whom, 
how long, and under what circumstances” these interventions work (Brown et al., 2009; 
Stice et al., 2009).
Some researchers have tested whether intervention effects vary across sample characteristics 
such as initial symptom severity (Sandler et al., 2003), gender (Clarke et al., 2001) or race 
and ethnicity (Cardemil, Reivich, Beevers, Seligman, & James, 2007; Marchand, Ng, Rohde, 
& Stice, 2010) but findings have not been consistent, and individual trials are often under-
powered for detecting such heterogeneity (Brown et al., 2013). Meta-analyses using meta-
regression provide some clues that preventive effects may vary depending on age, gender, 
and initial symptom severity (Horowitz & Garber, 2006; Merry et al., 2011; Stice et al., 
2009), but standard meta-regression methods, which depend on effect sizes aggregated at the 
trial level are severely under-powered for detecting such moderation effects (Dagne, Brown, 
Howe, Kellam, & Liu, 2016), and may be so severely biased that conclusions from aggregate 
data may be in the opposite direction of the true moderated effects at the individual level 
(Petkova, Tarpey, Huang, & Deng, 2013).
In this paper, we report results based on an aggregated dataset that combines longitudinal 
data from 5,210 adolescents participating in 19 trials of interventions that were either 
Brown et al. Page 2













designed to prevent depression or to prevent a broader set of behavioral problems or improve 
mental health. The use of individual-level data in this large dataset substantially increases 
power to detect heterogeneity, while avoiding many of the pitfalls of standard meta-
regression techniques (Brown et al., 2013). These data involve individual-level measurement 
of depressive symptoms through two years post-randomization, baseline participant 
characteristics, as well as intervention attributes that potentially serve as moderators of 
intervention effects. We employ novel statistical methods, combining techniques from 
integrative data analysis (Curran & Hussong, 2009; Greenbaum et al., 2015), latent variable 
analysis, and growth modeling (see Brincks et al., this issue) to test a series of hypotheses 
concerning heterogeneity of prevention effects.
Potential Sources of Heterogeneity of Intervention Effects
Existing prevention programs have been based on several different theoretical models. These 
include cognitive-behavioral theory (CBT) which focuses on improving youth cognitive 
styles and building coping skills (e.g., Clarke et al., 2001; Garber et al., 2009; Gillham et al., 
2012; Horowitz, Garber, Ciesla, Young, & Mufson, 2007); interpersonal psychotherapy 
(IPT) which aims to improve interpersonal skills and relationships and reduce conflict (e.g., 
Horowitz et al., 2007; Young, Mufson, & Davies, 2006; Young, Mufson, & Gallop, 2010); 
and parenting and family-systems (PFS) interventions, which attempt to improve parenting 
practices and family relationships (e.g., Connell & Dishion, 2008; Gonzales et al., 2012; 
Prado & Pantin, 2011; Trudeau, Spoth, Randall, Mason, & Shin, 2012). Some programs also 
combine approaches such as parenting and coping training (e.g., Compas et al., 2009; 
Sandler et al., 2003; Wolchik et al., 2000). Finally, some trials have examined the potential 
incremental benefits of adding a parent component to CBT- or IPT-based child-centered, 
preventive interventions, and have found no differences in effects (e.g., Gillham et al., 2012; 
Young et al., 2010), though the studies may have been underpowered to detect such effects.
Although the theoretical orientation of the intervention may influence intervention response, 
few studies have compared the effects of different types of preventive interventions. 
Horowitz et al. (2007) compared IPT and CBT prevention programs and found that by the 
end of the intervention, both reduced depressive symptoms with no significant differences 
between them, although both were significantly better than the no-intervention control 
condition. On the other hand, a meta-analysis of preventive interventions across the lifespan 
found some evidence that IPT-based programs were more effective than CBT-based 
interventions, but cautioned that this was based on only a few IPT-based studies (Cuijpers, 
van Straten, Smit, Mihalopoulos, & Beekman, 2008). We include trials testing all three types 
of interventions (CBT, IPT, PFS) in the current study, allowing us to test whether 
intervention type does moderate impact on depression.
Trials have also varied in their primary or focal targets. Some interventions have specifically 
targeted the prevention of depressive disorders and symptoms (e.g., Clarke et al., 2001; 
Garber et al., 2009; Gillham et al., 2012; Horowitz et al., 2007), whereas others have 
focused more broadly on promoting general mental health and preventing both internalizing 
and externalizing conditions (e.g., Sandler et al., 2003; Wolchik et al., 2000). Others have 
aimed to prevent youth externalizing symptoms (e.g., drug abuse, conduct problems), yet 
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have found significant protective effects on youth depressive and internalizing symptoms as 
well (Connell & Dishion, 2008; Perrino et al., 2014; Trudeau et al., 2012). These secondary 
effects on internalizing symptoms may be due to the influence of these interventions on 
common protective processes, such as positive parenting and family relationships (Perrino et 
al., 2014; Restifo & Bogels, 2009; Sander & McCarty, 2005), or to longer term 
developmental changes passing first through reductions in externalizing behavior (McClain 
et al., 2010; Perrino et al., in press). To date, no meta-analysis of the prevention of 
depression in youth has included intervention trials targeting externalizing problems, risky 
sexual behavior, or drug abuse. Thus, it is unclear whether the effects of these programs are 
similar to depression-specific programs and how the inclusion of these trials impacts overall 
effect sizes. To test this question, we included trials with different focal targets (depression 
alone, problem behavior, general mental health), allowing us to test whether the targets of 
these trials had different impacts on preventing depression.
There is also evidence from individual trials that population characteristics contribute to 
heterogeneity in the effects of preventive interventions on depressive disorders and 
depressive and internalizing symptoms. Individual trials have found that adolescent 
subgroups show different intervention response depending on age, gender, ethnicity, and 
initial levels of depressive symptoms (Horowitz & Garber, 2006; Merry et al., 2011; Stice et 
al., 2009). Stice et al.’s (2009) meta-analysis of trials targeting depression found greater 
trial-level effects for interventions involving older, higher risk participants (e.g., those with 
elevated depressive symptoms), as well as samples with greater proportions of female and 
non-white participants. Horowitz and Garber’s (2006) earlier meta-analysis of similar trials 
also concluded that there were larger effects for trials with higher proportions of females and 
higher risk participants, and identified larger effects for older versus younger adolescent 
participants.
However, findings from some individual trials have not been consistent with the meta-
analyses previously mentioned. For instance, Clarke, Hawkins, Murphy, and Sheeber (1993) 
found that boys responded more positively to a CBT-based preventive intervention than did 
girls. Regarding ethnicity, the Penn Resilience Program found beneficial effects on 
depressive symptoms for Hispanic but not African American youth (Cardemil et al., 2007). 
Using data from two studies, Marchand et al. (2010) found no differential effects of a CBT-
based prevention program for Asian, Latino and European American adolescents. Because 
many trials had limited representation of the broad diversity of youth, further research is 
needed to determine whether and which demographic or clinical variables moderate 
intervention outcomes. In the current study, we tested whether key demographic variables, 
including gender, age, race and ethnicity, parent education, and family income, as well as 
initial symptom severity moderated the impact of interventions on preventing depressive 
symptoms.
Analysis of Summary-Level versus Participant-Level Data across Trials
The inconsistent findings on moderators of intervention effects, together with the substantial 
variability across interventions and their samples, suggest the need for more in-depth 
approaches to synthesis of data from multiple trials. Single randomized trials are often 
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underpowered to detect intervention moderator effects and do not consistently report tests of 
the same moderator variables (Brown et al., 2013). Although meta-analysis has important 
strengths for the examination of main effects across trials, its utility for understanding 
intervention moderator effects is more limited (Brown et al., 2013; Kraemer, Wilson, 
Fairburn, & Agras, 2002; Lipsey, 2003). One concern is that non-significant moderator 
analyses typically are not published, limiting the information available to understand 
moderators through combining results of moderator analyses through meta-analysis. A 
related concern is that individual trials can conduct moderator analyses using different 
methods (e.g., continuous versus cut-points) and different variables, making it difficult to 
draw clear conclusions regarding moderators using a traditional meta-analytic approach 
(Brown et al., 2013).
A promising strategy for addressing the limitations of single trial analyses and meta-
analyses is to combine datasets from individual trials and conduct integrative data analysis 
(IDA), also known as individual patient level meta-analysis (Higgins, Whitehead, Turner, 
Omar, & Thompson, 2001; Stewart & Clarke, 1995). IDA is defined as an “analysis of 
multiple data sets that have been pooled into one” (Curran & Hussong, 2009; Curran et al., 
2014; Hussong, Curran, & Bauer, 2013), and in our case involves pooling individual-level 
data together across multiple trials and conducting synthesis analyses across similar studies. 
In general, IDA yields larger sample sizes, increased statistical power, increased variability 
on important measures, and the capacity to test more sophisticated models. IDA also can be 
applied to multiple randomized trials to assess moderation and mediation (Brown et al., 
2013; Gibbons, Brown, Hur, Davis, & Mann, 2012; Gibbons, Hur, Brown, Davis, & Mann, 
2012; Perrino et al., 2014).
IDA is particularly promising for evaluating individual-level moderators. Dagne et al. (2016) 
found that power to detect moderator effects for individual-level moderators could be as 
much as 16 times greater for IDA as compared to standard meta-regression. Unlike meta-
regression, IDA with individual-level data will not result in the ecological fallacy of 
interpreting group-level associations as reflecting individual-level effects.
Recent synthesis analyses demonstrate the potential benefits of IDA for understanding 
intervention moderator effects. For instance, Perrino et al. (2014) combined participant-level 
data from three trials of the Familias Unidas intervention, a family-focused intervention that 
has been found to promote family functioning, and to prevent drug abuse, externalizing 
problems, and HIV risk among Hispanic youth (Prado & Pantin, 2011). Using IDA 
techniques, this study found that parent-adolescent communication, a modifiable risk factor 
and hypothesized mechanism by which this intervention works, was a significant moderator 
of intervention effects on internalizing symptoms. Importantly, communication was not a 
significant moderator of intervention effects when combined analyses were conducted on 
each separate trial’s moderation findings, suggesting that IDA increased the statistical power 
needed to detect this effect (Perrino et al., 2014).
Similar IDA analyses have been used to examine treatment effects. Gibbons, Hur, et al. 
(2012) combined individual-level data from 41 antidepressant trials involving pediatric, 
adult, and geriatric populations, and found that age moderated treatment effects, with greater 
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reductions in depressive symptoms for children and adults as compared to patients over 60 
years of age. Greenbaum et al. (2015) used IDA to combine data from trials of 5 drug abuse 
treatment programs involving mutidimensional family therapy, finding stronger preventive 
effects on drug abuse for female adolescents and effects only for European American and 
African American but not Hispanic participants.
The Current Study
The current paper used IDA to test a series of hypotheses concerning overall impact of 
prevention programs over time and whether study-level and individual-level variables 
moderate the impact of preventive interventions on adolescent depression. We combined 
participant-level data from 19 randomized controlled trials that tested whether interventions 
prevented depressive symptoms. The combined dataset includes nine distinct preventive 
interventions and a total sample of 5,210 adolescent participants measured up to six times 
over two years after baseline, depending on the trial protocol. IDA was used to examine 
intervention effects on adolescent depressive symptom outcomes, as well as to identify 
factors that moderated intervention effects. Specifically, this paper examined the following 
questions: (1) Do preventive interventions have an overall effect on the course of adolescent 
depressive symptoms? (2) If so, does this effect remain constant (linear), increase, or 
decrease over time? (3) Do intervention effects differ by adolescents’ gender, age, and 
baseline level of depressive symptoms? (4) Do effects differ by type of intervention (i.e., 
CBT, IPT, PFS)? (5) Do effects differ by focal target of the intervention (i.e., depression 
alone, problem behaviors, or general mental health)?
Methods
Sample
We procured 19 full datasets from published trials of relevant preventive interventions. 
These trials all satisfied the following criteria: (1) the study must be described as having 
focal targets of adolescent depression alone, problem behaviors, or general mental health; 
(2) the study must randomize to intervention or control, although randomization could occur 
at the individual, family, or community level; (3) samples must include target participants 
between the ages of 11 and 18 upon enrollment, although a study could include other 
participants outside that age range; (4) the study must include measures of depressive or 
internalizing symptoms; and (5) symptom measures must be administered in at least one 
follow-up occurring at least 6 months after baseline, although most had much longer follow-
ups.
In obtaining these data from 19 trials, we initially contacted investigators who had 
conducted 24 prevention trials meeting these criteria, and who indicated interest in 
collaborating. After securing grant funding, we returned to these investigators in order to 
develop collaborative working arrangements (Perrino et al., 2013) for a detailed discussion 
of this stage of collaborative engagement). We were ultimately able to gain access to 
complete individual-level datasets from 18 of these 24 trials, and then obtained an additional 
trial from one of our collaborators, bringing the total to 19 (listed in Table 1 and PRISMA 
diagram is shown in Figure 1a).
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All trials were designed to randomize participants at the individual or family level, with one 
exception (Preparing for the Drug-Free Years, PDFY) which was randomized at the 
community level. All interventions were delivered by a trained professional, and included a 
range of intervention types such as parent skills training or prevention versions of CBT, IPT, 
or family based therapy. Whereas some trials targeted the prevention of adolescent 
depression specifically, others targeted problem behavior or general mental health 
promotion. Many of the trials included are considered effectiveness trials, although some are 
in the efficacy evaluation stage.
Some trials included children who were both inside and outside of our targeted age range. In 
those cases we selected only participants who fit our age criteria (between 11 and 18), 
eliminating 248 participants from further analysis. This left a combined sample of 5210. 
Sample characteristics for each trial are listed in Table 1. Participants ranged in age from 
preadolescent (ages 11-12: n=2751, 52.9%) to early adolescent (ages 13-15: n=2133, 40.9%) 
to older adolescent (ages 16-18: n=326, 6.3%). The sample was 49.8% female; 32.7% of 
participants identified as culturally Hispanic, 58.7% white, 9.5% African American, 1.8% 
Asian, 2.3% Native American, 0.6% Hawaiian or Pacific Islander, 3.8% other or multiracial, 
and 23.3% unknown; most of these unknowns were located in predominantly white, non-
Hispanic communities.
Although meta-analytic studies attempt to gather data from all relevant studies ever 
conducted on a particular topic, this is a difficult goal for IDA where full datasets are 
required. In order to provide information on how representative these 19 trials might be of 
the universe of possible trials, we conducted a comprehensive survey of published research 
using several citation databases. Details of this survey are described in Supplementary 
Figure A and an additional comparison can be found in a companion paper in this issue 
(Brincks et al., this issue). We identified a total of 68 additional prevention trials meeting our 
selection criteria. Supplemental Table B compares the 19 trials in our dataset with the other 
larger set of trials on several dimensions. The primary difference was that many of these 
other trials were conducted outside the United States. Nine of our 19 trials (47%) focused on 
preventing depression or internalizing behavior whereas 18(26%) of the other trials used 
were focused on preventing depression (Yates corrected p = 0.14). We thus obtained 33% of 
such existing trials for this synthesis project.. Trial sample sizes varied greatly but had 
similar means.
Measures
Outcome Measures—As the outcome measures for adolescent depressive and 
internalizing symptoms varied across the 19 trials, this presented a challenge in harmonizing 
outcomes across the studies. We identified eight measures of depressive symptoms that were 
used across the 19 trials. Some of these were limited to depressive symptoms; others 
included depressive symptoms mixed with other internalizing symptoms such as anxiety or 
withdrawal. We decided to keep these latter measures intact rather than using only 
depressive symptom items, given that they represent established measures of child 
functioning. In this paper we refer to this entire set as measures of depressive symptoms, 
given that depression items make up the vast majority of items.
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The eight measures included: 1. Children’s Depression Rating Scale (CDRS-R; clinician-
rated; (Poznanski & Mokros, 1996)), 2. Children’s Depression Inventory (CDI; self-report; 
(Kovacs & Beck, 1977)), 3. anxiety/depression subscale of the Youth Self-Report (YSR-
ANX/DEP; self-report; (Achenbach & Rescorla, 2001)), 4. withdrawal/depression subscale 
of the Youth Self-Report (YSR-WIT/DEP; self-report; (Achenbach & Rescorla, 2001)), 5. 
Center for Epidemiologic Studies – Depression Scale (CESD; self-report; (Radloff, 1977)), 
6. anxiety/withdrawal subscale of the Revised Behavior Problem Checklist (RBPC-ANX/
WIT; parent-report; (Quay, 1983)), 7. anxious/depression subscale of the Child Behavior 
Checklist (CBCL-ANX/DEP; parent-report; (Achenbach, 1991)), and 8. withdrawal/
depression subscale of the Child Behavior Checklist (CBCL-WIT/DEP; parent-report; 
(Achenbach, 1991)).
Whenever possible, we scored measures based on original items rather than relying on pre-
computed constructs in each of the trial datasets. This allowed us to standardize scoring 
across all trials (e.g., treat a scale as missing if less than 80% of its items were completed by 
the individual).
Some trials did not measure the entire set of available items on a particular instrument. For 
example, one trial administered a custom set of items closely related to the CDI to all 
participants, and the CDI to a smaller set (23%). The overlap of items between this custom 
measure and the CDI allowed us to regress the summary score for the custom measure on 
CDI in our model and thereby infer CDI scores on all participants. We used a similar 
approach for one trial that used a shortened version of the CESD at follow-up. With parent-
reported instruments, we chose the mother’s report over the father’s when available because 
the correlations between father’s report and other measures were not as strong as those for 
the mother. In the few cases where the mother’s report was not available, we used the father 
report.
Candidate Moderators—We limited our candidate moderators to variables that were 
collected in all or nearly all of our 19 trials. This included individual levels 
sociodemographic characteristics including race/ethnicity, age, gender, and family 
socioeconomic status, baseline level of depressive symptoms, characteristics of the 
intervention and how it was delivered.
Race/ethnicity was coded into the following non-mutually exclusive categories: Hispanic, 
Black/African American, Native American, Asian, White, Hawaiian, or Other/Multiple 
Race. When Hispanic ethnicity was missing or unknown, participants were categorized 
based on their self-identified race. Whereas the U.S. Census and the National Institutes of 
Health now consider race and ethnicity to be different concepts for which data should be 
collected separately (Grieco & Cassidy, 2001; National Institutes of Health, 2001), not all 
studies collected both race and ethnicity data, resulting in some incomplete data on these 
potential modifiers. Although there are limitations to the race/ethnicity categorization 
utilized in some of the earlier trials in this study, we decided to categorize Hispanics as a 
separate category that collapses across racial groups based on existing evidence that a 
significant proportion of Hispanics self-identify as “Hispanic” when asked to select a racial 
category, suggesting that this may better reflect the perceived identities of many U.S. 
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Hispanic individuals (Hitlin, Scott Brown, & Elder, 2006). This race/ethnicity categorization 
also maximizes the use of available data as some studies with Hispanics did not ask about 
race. For analyses where numbers were too small to conduct separate race/ethnicity analyses 
we created a minority classification by including all groups other than white non-Hispanic. 
A separate binary variable coded participants as minority (i.e., any racial or ethnic minority 
group) versus non-minority (i.e., white).
Other sociodemographic variables considered as moderators included age, gender, parent 
education and family income, all measured by parent report. Parent education was indexed 
as the highest grade attained by either parent. Annual family income in dollars was 
measured by parent report, using the mother’s report in the few instances that the two 
parents’ reported differed. In trials where income was reported by selecting one of several 
range categories, we used the mid-point of the range category endorsed.
Trial and Arm-Level Variables included intervention type, target participant and focal target. 
Using published reports of each trial, three staff members coded each trial independently on 
these variables, and we sought confirmation of the final coding from the primary study 
authors. Six trials included more than one active intervention arm, so several variables were 
coded by intervention arm rather than by trial. Intervention type was coded as one of three 
categories: cognitive behavioral, interpersonal, or family-based/parenting. Target participant 
variables indicated to whom the intervention was delivered. Three separate variables were 
developed to account for interventions with multiple components. Delivered to child was 
coded as a yes/no variable, indicating whether the child received at least a portion of the 
intervention without the parent present, in a youth group or individually. Delivered to parent 
was categorized to distinguish whether and how the parent received the intervention. This 
variable was coded using three possible codes: 1) parent received information only about 
what their child was learning in the intervention; 2) parent received more formal therapeutic 
intervention than information (e.g., cognitive behavioral or parenting skills training); or 3) 
no parent contact. Focal target was coded as a binary variable: we identified trials as 
depression-focused when the explicitly stated target of the intervention was the prevention of 
a depressive disorder or reduction of depressive symptoms, and problem behavior or general 
mental health when the focal target was some form of problem behavior or broader mental 
health promotion.
Missing Data Strategy
The dataset formed by combining data from the 19 trials was quite complex, because each 
trial employed only a small subset of the eight depressive symptom measures, and different 
trials used different follow-up periods. We approached this as a multivariate missing data 
problem. The details of this modeling approach are reported in Brincks et al (this issue); 
here we provide a brief overview.
Scores on depression measures were not available when participants failed to complete a 
measure or participate in a particular measurement occasion. These scores were all set to 
missing. In addition, when a trial did not use a particular depression measure, we assigned 
scores on that measure to missing for all participants in that trial. We used standard full-
information maximum likelihood methods to deal with these forms of missingness. These 
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methods assume that data are missing at random, that is, the occurrence of missing data is 
not associated with unobserved values (Rubin, 1976). . At the trial level, missingness often 
occurred because a measure was not used in that trial. By conditioning on trial in our 
analysis, this is a type of missingness at random. Within each trial, missingness was 
primarily due to attrition. Because each trial had follow-up evaluations conducted by 
assessors masked to intervention condition, any potential departures from missing at random 
within a trial would likely be comparable across conditions.
Given that trials used different follow-up periods, we attempted to employ random effects 
modeling methods that allowed time of measurement to vary across respondents. These 
models failed to converge, given the complexity of the full model. We then decided to use a 
harmonization strategy.
In order to use general models involving multivariate growth modeling for panel data, we 
condensed follow-up measures into six time blocks that had reasonably narrow widths. We 
did this because the analysis of panel data provided more flexibility than did other 
procedures that treated follow-up times as continuous (e.g., we could examine growth 
mixture models; B. O. Muthén et al., 2002). The resulting time blocks were: baseline (time 
0), 7 days to 2 months (time 1), 2 months – 3 months (time 2), 5.5 months – 6 months (time 
3), 9 months – 14 months (time 4), 14 months – 18 months (time 5) and 24 months (time 6). 
Figure 2 identifies the number of youth at baseline enrolled into the trial within ages 11-18, 
and shows the availability of follow-up data for each of the trials at each time period up to 
24 months post-intervention. Note that all time blocks had some data available across all 
these 19 trials, with 5 of the trials measured up to 24 months, and all trials had at least one 
assessment through 14 to 18 months. Only a few trials had measures at time 1 (7 days to 2 
months), and all of those that did also had measures at time 2 (2 months to 3 months). 
Because of the limited amount of data available at the first follow-up time block (time 1), the 
estimates at this time point were expected to be unstable. As all of the trials that had data at 
time 1 also had data at time 2, we did not include the first follow-up data in our modeling. 
This resulted in the loss of only 2.9% of all data.
Statistical Modeling
Testing for Change across Time—The major analytic challenge in this paper 
summarizes individual growth trajectories across time and outcome measure. At each time 
block there were multiple measures of depressive symptoms, with varying levels of overlap 
across trials as specified in Siddique, de Chavez, Howe, Cruden, and Brown (this issue). 
Because all the depressive symptom measures related to a single underlying construct, we 
chose to model these multiple measures as a latent variable, in a second-order latent growth 
model, as described in detail in Brincks et al. (this issue). Across the six time blocks, we 
constrained the loadings and intercepts on the measurement model for depressive symptoms 
to be equal, and allowed the factor variances to change with time and covariates. This 
allowed us to examine how trajectories of these latent variables changed over time.
We allowed our modeling of the growth over time, i.e., “slope,” to capture any linear as well 
as nonlinear pattern across time points. This is especially important in prevention as many 
prevention effects may diminish or even reverse over time, and such patterns would not be 
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detected if we forced the pattern to be linear. Nonlinearity was accounted for by allowing the 
second-level factor loadings of the growth model to be estimated by the data, allowing the 
estimation of all but the first two loadings, which were fixed to force identifiability.
Our second-order latent growth model included a latent variable for baseline depressive 
symptoms (Intercept) and a latent variable for change on depressive symptoms (Slope), see 
equations in Brincks et al. (this issue). In our structural equation modeling we controlled on 
demographic variables age, gender, race/ethnicity, family income, and parent’s educational 
attainment for both the second-level intercept and slope. We also adjusted the intercept and 
the slope, for trial as a fixed effect in all these second-order latent growth models. This 
introduction of fixed effects for trial was used instead of random effects because the number 
of trials was too small to estimate these variances and covariances with sufficient precision 
and concern that single random effects may not represent trial level heterogeneity 
sufficiently well. Because baseline levels of depressive symptoms may well influence the 
symptom trajectory of internalizing, we regressed the slope on the intercept to control for 
baseline internalizing symptoms. A test of moderation of the intervention effect on slope 
trajectory by baseline level of depressive symptoms was conducted by testing whether the 
regression coefficients of the latent slope on the latent intercept were different for 
intervention versus control.
Testing for Main Effects of Intervention on Depression Trajectories—In the 
second-order growth model, main effects of the intervention on the trajectory of adolescent 
depressive symptoms were tested by regressing the latent slope on intervention condition, 
see equations in Brincks et al. (this issue). This was coded so that a negative coefficient 
indicated more rapid reduction for intervention compared to control conditions. We tested 
the overall effect of intervention versus control using the estimated coefficient and a Wald 
test based on robust standard errors from this analysis. An effect size (ES) is calculated for 
these effects by dividing the difference in intervention versus control slopes with the pooled 
standard deviation of the slopes after adjustment for the intercept and baseline covariates. 
Negative ESs imply that symptoms improved more for intervention than for control.
Testing for Variation in Intervention Impact on Depression Trajectories—We 
conducted a number of tests to examine variation in impact. Moderation of the intervention 
effect on slope trajectory by baseline level of depressive symptoms was examined by testing 
whether the regression coefficients of the latent slope on the latent intercept differed by 
intervention condition, see equations in Brincks et al. (this issue). All individual-level 
moderator effects mentioned earlier were tested similarly by Wald-type tests of the 
interaction between the intervention condition and the moderator of interest.
We were also interested in characteristics of the intervention that may moderate treatment 
effects, such as type of intervention (CBT, IPT, PFS), target of the intervention (child, 
parent, conjoint) and whether the trial specifically targeted depression as an outcome. To 
conduct these analyses, we attempted two-level growth modeling (i.e., three level mixed 
effects modeling involving time, person, and arm of trial) in Mplus (L. K. Muthén & 
Muthén, 1998-2015). As these analyses did not converge due to the modest number of trial 
arms (24) fit with two correlated random effects, we instead estimated intervention effects 
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using the second-order growth model with slope regressed on each trial (adjusting for 
intercept and individual level covariates), and extracted these adjusted empirical Bayes 
estimates and their standard errors into a separate dataset with adjustments for trials that had 
two active intervention arms compared to the same control, as described in Brincks et al. 
(this issue).
In addition to formal testing for moderation effects of individual-level and arm-level 
predictors, we examined variation in impact three other ways. First, we conducted growth 
mixture models to assess whether impact varied by different patterns in growth of symptoms 
over time (B. O. Muthén et al., 2002). Second, we summarized the distribution of arm-level 
effects graphically in a smooth histogram by simulating the distribution of the contrasts 
using the empirical Bayes estimates and their standard errors. Third, we summarized 
variations in intervention versus control differences in impact using two-level regression 
analysis both as single moderator effects as well as effects adjusting for other potential 
moderators.
Mplus Version 7.3 (L. K. Muthén & Muthén, 1998-2015) was used to evaluate all structural 
equation models, using comparative fit indices (CFI) and root mean square error of 
approximation (RMSEA) to assess overall model fit and chi-square and Wald tests to 
compare nested models. We use as guides to good model fitting the rules of Browne and 
Cudeck (RMSEA < 0.05; 1993) and Hu & Bentler, (CFI > 0.90; 1999). R (R Core Team, 
2015) was used to conduct orthogonal transforms and simulations.
Results
Balance across intervention condition
To compare baseline characteristics between the intervention and control groups, we 
performed Mantel-Haenszel tests of conditional independence for binary variables and 
random intercept multilevel model testing for continuous variables. As shown in Table 2, the 
numbers of subjects in these 19 trials was far from evenly divided by intervention (N = 
3098) and control group (N = 2112), reflecting the fact that 5 trials had two active arms and 
one control, and a few trials intentionally randomized more youth to intervention rather than 
control. The proportion of youth excluded from our analyses as a result of age (younger than 
11 or older than 18) differed modestly across intervention condition (5.5% control 
participants excluded vs. 6.9% intervention participants excluded, χ2 = 4.12, p = 0.04). 
After removing these observations, there was a total of 5,210 observations. No significant 
differences by intervention condition were found on the average number of times measured 
(4.06 times for the intervention group and 3.81 times in the control group; p = 0.77) nor on 
the average number of different symptom measures assessed (the intervention group 
averaged 1.70 of the 8 different depressive symptom measures, while the average in the 
control group was 1.81, p = 0.11). Overall, there were no differences in baseline levels of 
gender, race/ethnicity, parent education level, or whether income information was missing. 
However, the intervention group reported a higher mean household income, $43,000, 
compared to $39,000 in the control group, an effect size difference of 0.13, p < 0.001). Also 
the intervention group was less likely to have a missing value on parent education level 
compared to control (23.6% vs. 29.7%, Mantel-Haenszel χ2 = 24.8, p < 0.001). Lower 
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scores on income and parent education are associated with higher rates of depressive 
symptoms, and therefore these two variables are included as covariates in all analyses.
Comparison of baseline level of depression symptoms
Our conclusions about intervention impact on the course of depression would be hampered 
if there were differences between intervention and control at baseline or if the underlying 
factor model of depressive symptom scores differed by intervention condition. We therefore 
began with a comparison of means on each of the observed baseline measures. Overall, there 
were no significant differences in baseline levels of any of the 8 depressive symptom 
measures rated by the child (CDI, YSR-Anx/Dep, YSR-Wit/Dep, CESD), parent (RBPC-
Anx/Wit, CBCL-Anx/Dep, CBCL-Wit/Dep) or clinician (CDRS), see Table 2.
Because of the high proportion of missing data on each of these individual variables we 
conducted an overall test based on a single factor model (see last row of Table 2). A model 
that enforced similar factor structures at baseline demonstrated adequate fit to the data 
χ2(288) = 772.18, p < 0.001; CFI = 0.88, RMSEA = 0.018). The model that allowed the 
latent variable’s loadings on the eight depressive symptom measures to differ by intervention 
condition did not improve the fit (χ2(8) = 9.15, p = 0.33), further suggesting comparability. 
The factor model indicated that the eight proposed indicators of depression symptoms all 
loaded significantly onto a single latent construct. The standardized factor loadings at 
baseline ranged from a low of 0.18 for RBPC anxiety/withdrawal to a high of 0.999 for 
CESD. The single clinician measure of CDRS-R had a standardized loading of λ= 0.35, 
which was much lower than CDI (λ = 0.84), YSR-ANX/DEP (λ = 0.89) and YSR-
WIT/DEP (λ = 0.89). This indicated more measurement error for one parent report, 
moderate measurement error for the clinician rating and two parent ratings, and lowest 
measurement error for the four self-reported measures. Based on this latent variable model, 
we computed the average level of depressive symptoms at baseline across all subjects. The 
baseline mean on the CESD scale was 13.42 (SD = 9.35), a few points below the clinical 
level of 16, indicating mild depression (Radloff, 1977). This translates to approximately 
40% of our sample having symptom levels above a mild clinical level at baseline on the 
CESD scale.
To test for baseline differences in depressive symptoms, the latent factor was regressed on 
intervention condition after adjusting for individual level covariates of age, gender, race/
ethnicity, family income and parent education level. As expected in randomized trials, the 
baseline level of depression did not significantly differ by intervention condition (b = 0.002, 
se = 0.036, p = 0.95) nor did this conclusion change when trials were entered as fixed 
factors.
Associations between covariates and baseline depressive symptoms
The baseline level of depressive symptoms was marginally significantly and positively 
related to age (b = 0.037, se = 0.019, p = 0.055), and negatively related to being male (b = 
−0.267, se = 0.036, p < 0.001), household income (b = −0.036, se = 0.008, p < 0.001), and 
parent education level (b = −0.050, se = 0.021, p = 0.016). After adjustment for trial there 
Brown et al. Page 13













was no significant difference in baseline symptom scores for Hispanics, African Americans, 
or White non-Hispanics (χ2 = 0.367 on 2 df, p =0.83).
Second-order latent growth modeling
In this section, we first discuss the general pattern of growth trajectories we found across 
time and trial. In our second-level growth modeling analysis involving time points 0 through 
6 leaving out time point 1 as discussed above, we allowed for potential nonlinear growth by 
fixing the first two loadings, then estimating the loadings for time points 3-6. The estimated 
loadings provide a general shape of a curve of the general pattern of symptom change over 
time, shown in Figure 3, which shows the plot of time against the optimal transformed scale 
of time. Note that the curve very closely resembles an inverse transformation of time rather 
than being linear. Thus, depending on the sign of the slope coefficient from our analyses, the 
pattern of change would show an immediate rise in symptoms (for a positive slope) or an 
immediate lowering of symptoms (for a negative slope), followed by a slower rise or fall to 
an asymptote that is reached over two years. In our analyses below, regressing the latent 
slope on intervention condition will result in a negative coefficient if those in the 
intervention group show a faster decrease in symptoms compared to controls. This 
corresponds in a mixed effects growth model to an interaction term between intervention 
condition and this transformed time scale. These loadings were estimated in the main effects 
model, and the values were fixed to these estimates for all subsequent analyses (except 
growth mixture models) to provide direct comparability across analyses.
Intervention effect on change in depressive symptoms
The next analysis examined the overall effect of intervention on the change in depressive 
symptoms over the 24-month follow-up period. In this analysis, the depression factor 
loadings and intercepts were constrained to be equal across time points. Because we 
detected no significant differences at baseline and we wanted to make comparisons across 
intervention condition, we constrained the relationship between the latent intercept as well 
as all covariates to be equal for intervention and control conditions. We also constrained the 
relationship between the latent trajectory and the latent baseline level (intercept) to be equal 
across intervention condition. In these analyses, trial membership was treated as a fixed 
effect with 18 dummy-coded variables included as predictors of the intercept and slope, and 
fixed equal across intervention condition. There was a significant mean difference in the 
trajectory of depressive symptoms (b = −0.439, se = 0.224, Wald test = 3.852, df = 1, p = 
0.050), with a larger reduction in depressive symptoms over time for those receiving 
intervention compared to control. Across all the trials this overall effect size is 0.09 (95% CI 
0.00, 0.19).
Moderators of intervention effect
Our next series of analyses tested for moderation of intervention effects by (1) 
characteristics of the participant, including baseline measures of depressive symptoms, age, 
gender, and race/ethnicity, (2) family income and parent education, and (3) trial 
characteristics, including whether the intervention targeted depression directly.
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Baseline depression—To examine whether baseline depression moderated the 
intervention effect on the trajectory of depressive symptoms, we first tested whether the 
regression of the slope on intercept differed by intervention condition. Baseline depressive 
symptoms was a significant, negative predictor of change in depression symptoms across 
both intervention and control conditions (control: b = −0.39, se = 0.04, p < 0.001; 
intervention: b = −0.41, se = 0.04, p < 0.001) and this relationship between intercept and 
slope did not vary by intervention condition (Wald test = 0.42, df = 1, p = 0.52), indicating 
no moderation effect of baseline depression severity. These results suggest that higher 
symptom levels at baseline led to faster reductions in depressive symptoms for both 
intervention and control participants, a point we will elaborate in later analyses presented in 
this paper.
Age: We found no significant relationships between participant age and trajectory of 
depressive symptoms for both control youth (b = 0.17, se = 0.14, p = 0.24), and intervention 
youth (b = 0.10, se = 0.14, p = 0.47). These effects were not significantly different across 
condition (Wald test = 0.21, df = 1, p = 0.65) indicating no moderation effect by age.
Gender: Gender was not a significant predictor of trajectory of depressive symptoms among 
control youth (b = −0.37, se = 0.30, p = 0.23). However, among intervention youth, males 
experienced significantly faster declines in symptoms compared to females ( b = −1.21, se = 
0.28, p < 0.001). The relationship between gender and trajectory of depressive symptoms 
was significantly different across condition; that is, males benefit more from intervention 
than females (Wald test = 4.33 df = 1, p = 0.037).
Race/Ethnicity: We found no significant moderation of overall intervention impact 
compared to control by race or ethnicity across Hispanic, White-Non-Hispanic, African 
American or other minority (Wald test = 4.242, df = 3, p = 0.24).
Family Income: Income did not moderate the intervention impact (b = 0.014, se = 0.073, p 
= 0.85).
Parent Education: Education also did not moderate the intervention impact (b = 0.134, se = 
0.861, p =0.407).
Intervention target: Among the 19 trials in this synthesis, nine directly targeted depression 
as a primary outcome, whereas the remainder were other-focused trials that targeted problem 
behavior or general mental health. Given this important distinction in trial focus, we 
examined intervention effects within these two subgroups of trials. We note first that there 
were important differences among the participants in these two types of trials. Participants in 
the depression-focused trials had much higher baseline levels of depressive symptoms 
compared to those in the problem behavior or general mental health of trials. Specifically, 
those in the depression-focused trials started a full 1.59 standard deviations higher in 
symptoms than those in the problem behavior or general mental health trials. We also 
discovered baseline differences on measures of socio-economic status across these two types 
of trials. The mean household income among participants in the depression-focused trials 
was $61,854 (SD = $30,019) and only $30,882 (SD = $28,081) among participants in 
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problem behavior or general mental health trials. Thus, on average those in depression-
focused trials lived in families with twice as high incomes. Similarly, 98% of the parents in 
the depression-focused trials had at least a high school degree, while only 74% of parents in 
the problem behavior or general mental health trials completed high school degree. Of 
parents in the depression-focused trials, 82% had attended at least some college, but only 
46% of the parents in the problem behavior or general mental health trials had attended 
college. Thus, similar to baseline level of depressive symptoms and income, there is a large 
difference in the distribution of education by whether trials are depression-focused or 
problem behavior or general mental health (chi-square = 841.49, df = 4, p < 0.001).
After controlling for all baseline measures, we found there was a significant and strong 
intervention effect among depression-focused trials. Those in the control condition in the 
nine depression-focused trials showed decreasing levels of symptoms overall, but those in 
the depression-focused intervention decreased more rapidly over the two years (second 
highest curve). The differences in the trajectories of depression-focused trials were 
significant ( b = −1.093 CI = (−1.763 −0.422), p = 0.001) and of substantial magnitude (ES 
= −0.239). In the problem behavior or general mental health trials, the mean trajectory of 
depressive symptoms was not significantly different across condition (b = 0.034, CI = 
(−0.515, 0.583), p = 0.903); both intervention and control equally reduced symptoms over 
time.
Given the much higher baseline depressive symptoms for depression-focused trials, we 
conducted a growth mixture analysis (B. O. Muthén et al., 2002) to examine whether 
depression-focused intervention conditions reduced symptoms more for those with high 
baseline depressive symptoms compared to control. We found two distinct classes separated 
by their baseline symptom level. About 40% of the sample was in the high class with 
average symptom levels 2-4 points below the clinically significant cutoff value of 20 on the 
CDI. The proportion in trials that focused on depression who fell in this high baseline group 
was 45% while those in the problem behavior and mental health focused interventions was 
slightly lower at 38%, which was only marginally lower (p = 0.05). For these high-symptom 
youth the depression-focused interventions reduced symptoms significantly (b = −2.01, SE = 
1.02, p = 0.050). There was no intervention effect among those with high levels of 
symptoms at baseline who were in the problem behavior or general mental health 
interventions, nor was there any impact for either depression-focused or problem behavior or 
general mental health trials among those who started with low levels of depressive 
symptoms. We also replicated these growth mixture analysis findings by fitting separate 
growth models for those who had at least one baseline depression scores above the 60th 
percentile and for those who had no high baseline symptom scores. Figure 4 shows the 
changes across time in symptoms, calibrated against the CDI scale even though not all trials 
used this measure (see details in Brincks et al., this issue). The two uppermost curves 
indicate sustained impact of depression focused prevention programs over control conditions 
for those who started with high symptoms. The bottommost curves in Figure 4 show no 
impact for any of those who begin with low symptoms; there is also no elevation in these 
symptoms across time (b = −0.105, se = 0.15, p = 0.47).
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We looked further to see if there were any variations among impact involving depression-
focused interventions on youth with high levels of symptoms. In particular, we examined if 
there was a difference in impact among the depression focused interventions for those that 
targeted the child directly or not (i.e. only targeted the parents). Among this highest risk 
group at baseline, programs that specifically targeted the youth were much more effective in 
reducing symptoms than those targeting parents alone (b = −3.525, SE = 0.888, p < 0.001).
Moderation of Intervention effects by Type of Intervention
Among the 19 trials, there were five trials that had two active intervention arms. Thus, a total 
of 24 active interventions were used in these trials. We were unable to create 
computationally accurate second-order growth models that accounted for all arm-level 
factors in one single analysis due to the large amount of missing data and relatively few 
arms. Instead, we calculated arm-level intervention versus control impact on the slope of 
depressive symptoms for each of the 24 arms using dummy variables for arm, and adjusting 
for age, gender, race/ethnicity, parent education, family income, and baseline levels of 
depressive symptoms in each trial. The 24 arm-level interactions between each active 
intervention and control were then entered into a next stage analysis, using as input the 
empirical Bayes estimates, their standard errors, and in the case of the 5 trials with 2 active 
intervention arms, their correlations. A summary of the 24 effects is shown in a smoothed 
density plot in Figure 5 that takes into account the uncertainty in each of these estimates. 
The effects on this figure are scaled in multiples of the overall standard deviation of the 
slope, i.e. effect sizes. Seventy percent of the mass is below zero, indicating an overall 
beneficial effect of these interventions compared to their respective controls. Nearly half 
(49.7%) of the mass is below −½ standard deviation; one third of the mass shows a large 
beneficial effect size, more extreme than −1 standard deviation. On the other end of the 
distribution 15% of the mass is above the ½ standard deviation.
These empirical Bayes summary statistics were analyzed in a two-level analysis, in order to 
examine arm-level effects both singly and in combination. We focused on six indexes of 
intervention type, using six dummy codes for whether the intervention included components 
that were delivered to the adolescent, delivered to the parent, or delivered conjointly, as well 
as whether the theoretical orientation of the intervention involved CBT, IPT, or PFS. These 
were not independent contrasts: for example, among the 18 arms where the child received 
intervention directly, 10 of these also included a parent-focused intervention. In addition, 
theoretical orientation was associated with participant type, with CBT interventions much 
more likely to include only the adolescent.
We first specified a model that included all six variables. None of the effects were 
significant, indicating that none of these intervention-level attributes independently 
accounted for differences in intervention effect. We then conducted exploratory analyses 
with each variable separately. Child-focused interventions showed a large reduction in 
symptoms over their controls compared to those that were not child-focused (b = −1.418, SE 
= 0.502, p = 0.005). No other individual moderator effects were significant.
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Our analyses demonstrated significant overall impact across the 19 trials of intervention 
versus control on depressive symptoms two years post randomization. Collectively, these 
interventions significantly reduced depression symptoms over the first year, and reduction of 
symptoms was maintained up to two years after the intervention. This pattern of stable 
symptom reduction is exactly what one would want to see from indicated prevention 
programs working with adolescents having elevated symptoms of depression at baseline. In 
the intervention group the reduction in symptoms was 10% stronger than that of the control 
group relative to the standard deviation in the control group. As a whole, these interventions 
showed a preponderance of beneficial effects with half of the preventive effect sizes 
above1/2 standard deviation. This finding supports those of previous meta-analyses of 
interventions to prevent youth depression (Horowitz & Garber, 2006; Merry et al., 2011; 
Stice et al., 2009). The results add to these existing findings by including problem behavior 
or general mental health trials besides depression-focused trials in the analyses.
There was evidence that these interventions varied in their impact and showed different 
effects on those with higher levels of symptoms. We found that interventions that 
specifically targeted depression, most of these having cognitive behavioral or interpersonal 
prevention components, had a beneficial effect (ES = −0.24), whereas those not specifically 
focusing on depression showed no overall effect. The impact of these depression-focused 
interventions over two years was limited to those who began with high levels of symptoms. 
In the absence of intervention, these youth remained near the clinically significant level 
whereas those given a depression-focused intervention showed a reduction in their 
symptoms. We detected no change among youth whose depressive symptoms began at very 
low levels.
Our effect sizes are on the same order as those reported from meta-analyses. Horowitz and 
Garber (2006), whose meta-analysis of 30 trials that included a broader range of 
interventions than we selected here in terms of age of youth but a more limited variation in 
type of intervention, reported an overall ES of −0.16 at follow-up (typically 6 months), 
compared to our −0.09 across two years, and their selective and indicated ESs of −0.30 and 
−0.23, respectively, were close to our ES of −0.24 for depression-focused trials among youth 
with high baseline depression scores. Stice and colleagues (2009), examining 47 trials, 
reported similar values as did Merry et al. (2011) who reported a 12-month ES of −0.20 for 
targeted interventions, and Sandler and colleagues (2014) who conducted an overview of 
existing meta-analyses, obtaining an ES of 0.19 for effects up to one year.
Our conclusion about the length of benefit of these prevention programs is stronger than that 
suggested by existing reviews (Horowitz & Garber, 2006; Merry et al., 2011). Merry 
concluded there were no effects by 24 months, but a modest effect at 36 months. Even 
though the meta-analyses are based on a larger numbers of trials than we had, their 
proportion of trials reporting data at a specific times is small, and cannot take time into 
account the way we did with growth curve analyses, nor the added precision of using 
individual level covariates.
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In addition to reporting continuing impact through two years, our integrative data analysis 
was able to examine individual level moderation by age, gender, or race/ethnicity that was 
not available to these meta-analyses. We found consistent evidence that males benefitted 
more from intervention than did females. This is different from a previous review (Garber & 
Downs, 2011) that noted a nonsignificant advantage for males, and ecologic analyses using 
percent of females in the trial, (Horowitz & Garber, 2006; Stice et al., 2009), which suggest 
that trials with greater proportions of female participants show stronger intervention 
response. In our synthesis there was no evidence of moderation by age, race/ethnicity, 
education level or family income. We do not consider the question of moderation effects 
across these variables as closed, but this provides some evidence that youth of different ages 
and from different racial/ ethnic backgrounds seem to respond similarly to these preventive 
interventions. Because few studies measured parental psychopathology we were not able to 
test whether there was a robust variation in impact by level of parental depression as 
reported by Garber and colleagues (2009).
Because some of the problem behavior or general mental health interventions (i.e., those not 
specifically targeting depressive symptoms) have previously reported significant findings on 
reduction of symptoms of depression (Connell & Dishion, 2008; Perrino et al., 2014; 
Sandler et al., 2003; Trudeau et al., 2012; Wolchik et al., 2013), we also included in our 
synthesis a set of these trials. The synthesis analyses suggest that unlike the depression-
focused interventions, these problem behavior or general mental health interventions did not 
show a significant reduction in overall effects on depressive symptoms compared to controls 
over the two-year post randomization period. Several issues should be noted in interpreting 
these findings. Overall, adolescents entered these problem behavior or general mental health 
intervention trials with substantially lower depressive symptoms as compared with those in 
the depression focused interventions. In addition, both intervention and control adolescents 
in the problem behavior or general mental health interventions maintained low levels of 
depressive symptoms comparable to those of the depression-focused intervention group 
through two-year follow-up. This suggests that adolescents in the problem behavior or 
general mental health trials were as a group at much less risk for depression during the 
period of development studied here, and there was little room for these interventions to show 
improvement. Even for those who had elevated symptoms at baseline, exposure to 
interventions that did not specifically targeted depression showed a non-significant effect on 
the course of depressive symptoms. We note that our null findings through two years on 
depressive symptoms for problem behavior or general mental health preventive interventions 
does not account for the potential for later impact as others have found at 3 years (Connell & 
Dishion, 2008) and 15 years (Wolchik et al., 2013). Follow-up periods longer than two years 
examined in the present analyses may be necessary to capture the potential cascading effects 
of problem behavior or general mental health interventions
Most parenting/family programs in this set of studies were designed to prevent problem 
behavior or promote mental health, and indeed most of these studies have reported effects on 
these outcomes within the two year follow-up studied here. There is evidence that problem 
behaviors constitute a separate pathway to subsequent depression, with depression emerging 
only after these behaviors have become established and disrupted adolescent development 
(Wolchik et al., 2013). This reflects the “dual failure model” which suggests that across 
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time, early behavioral and conduct problems contribute to poor social and academic 
competence, which subsequently increases susceptibility to depressive or internalizing 
symptoms (Capaldi, 1992; Capaldi & Stoolmiller, 1999; Moilanen, Shaw, & Maxwell, 
2010). Depression has been described as having complex and multifactorial causes (Garber, 
2006), for which different risk groups and pathways exist. Indeed, longitudinal mediation 
analyses of family focused parenting programs have found support for both earlier effects on 
internalizing problems and effects on academic problems as mediating pathways leading 
term effects on depression symptoms (Sandler, Ingram, Wolchik, Tein, & Winslow, 2015; 
Trudeau et al., 2012). Further research is needed to identify how intervention effects to 
change earlier developmental processes have a cascading effect to impact the long-term 
development of depression. As such, preventive interventions that target the most relevant 
risk and protective factors for distinct at-risk groups may be needed. An additional pathway 
for these “other” focused intervention may be on maternal depression, the relief of which 
can have a salutary effect on their children’s depressive trajectories.
In addition, other evidence suggests that the samples in depression-focused studies had very 
different risk profiles compared to those in the problem behaviors or general mental health 
preventive trials. Most of the depression-focused programs selected adolescents who had 
elevated but sub-clinical depressive symptoms at baseline, and some trials had a substantial 
percentage of adolescents with prior history of major depressive episodes (Clarke et al., 
2001; Garber et al., 2009).
It is also possible that the preventive impact of these interventions may occur for youth 
having baseline risk factors for depression other than elevated depressive symptoms. For 
instance, Perrino et al. (2014), in analyzing three Familias Unidas trials that varied by 
adolescent externalizing risk status, found evidence that adolescents in families having poor 
parent-adolescent communication at baseline demonstrated reductions in internalizing 
symptoms following this family/parenting intervention. There was no evidence for such 
effects in families with good communication. Again, this supports the existence of diverse 
risk pathways contributing to adolescent depression. Indeed, poor parenting and family 
relationships can place youth at risk for depression (Restifo & Bogels, 2009), and as such, a 
direct focus on improving parent-child communication provided by parent and family 
interventions may address different key risk processes for depression in some youth. It was 
not possible to examine family communication as a moderator across all 19 trials because 
parent-child communication was not measured in all these trials.
Methodologic Strengths and Limitations
These findings represent what we believe is the largest analysis of individual-level data on 
the prevention of depression. Analysis of individual level data provides a much richer 
opportunity for synthesizing findings than does meta-analysis. In particular, IDA produces a 
new analyses of individual level data, unlike meta-analyses, which must rely on the varied 
analytic decisions of each research team that contribute to the published statistics. Finally, 
we had access to detailed information about these trials from those most familiar with these 
studies. This collaborative data synthesis study worked to involve principal investigators and 
research teams from the original, individual trials to help guide and confirm the quality of 
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the data, analyses, and interpretations. (See Perrino et al., 2013 for further description of this 
collaborative data synthesis study).
We view one strength of this synthesis is the diverse set of interventions that are examined. It 
is feasible and appropriate to use IDA on a more homogeneous set of interventions than our 
set (e.g., one that was limited to depression-focused preventive interventions), but despite 
our wider trial inclusion, were able to pull out the much stronger effect that the depression-
focused trials had on those with high baseline symptoms.
This study has several limitations that need to be kept in mind. Our sample of trials does not 
include all possible trials of depression-focused and problem behavior or general mental 
health preventive interventions for adolescents. Nevertheless, our comparison with other 
published trials (supplemental material) and a comparison with effect sizes for trials 
identified in meta-analyses (Brincks et al., this issue; Sandler et al., 2014) did not reveal any 
obvious selection bias. Our set of trials is not fully representative. We did cover a diverse set 
of populations and interventions in the set of trials to improve power for testing moderation 
(Brown et al., 2013), and although we included a number of trials that focused on Hispanics, 
we did not include any that were focused only on African American or other populations 
that differed from the dominant culture group. We have argued that the pool of trials 
focusing solely on minority populations, as well as the percentage of minorities in the trials 
themselves, still remain lower than that needed to produce sufficient evidence of impact 
across these different populations (Perrino et al., 2015).
Another limitation is lack of data on parental depression on many trials; parental depression 
has been shown to be a negative moderator of intervention outcome for CB treatment as well 
as prevention of depression (Brent et al., 2015; Brent et al., 1998; Garber et al., 2009; 
Lewinsohn, Rohde, & Seeley, 1998). We were unable to examine whether parent depression 
at baseline moderated the effects across these preventive interventions, because this variable 
was only measured in a few trials. In addition, trials vary substantially in the way the 
moderators themselves were measured. We were able to harmonize single items of family 
income and parent education despite the fact that these were categorized differently across 
studies, but found it difficult to harmonize multi-item constructs like parenting because the 
items across studies were conceptually very different. As a result, the set of trials that meets 
all requirements for conducting an IDA moderator analysis would still be smaller than the 
set of trials that have tested relevant main effects. This points to potential benefits of the 
routine use of common measures in randomized trials, as now being promoted through the 
PhenX Toolkit (https://www.phenxtoolkit.org/).
Our total dataset also had a complex pattern of missing data, given that trials employed 
different measures of depressive symptoms and collected follow-up data at different times. 
The quantitative methods we developed to analyze these data and deal with this missingness 
are novel, and conditions under which their assumptions hold need to be explored more 
thoroughly. We discuss these assumptions and potential limitations more fully in Brincks et 
al. (this issue) and Siddique et al. (this issue).
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The vast majority of the trials did not assess diagnoses of major depression disorder so we 
do not reporting the impact on diagnoses averted by these interventions. Whereas we found 
important evidence of moderation effects at the individual and trial level, we have not fully 
investigated impact across all subgroups. Additional studies are underway to examine the 
impact of these interventions by exposure to socioeconomic adversity. This is important 
given the substantial differences in participants’ socioeconomic and educational 
disadvantage across type of prevention trial, as noted in the current paper’s results section.
Further, as few of these trials directly tested two active interventions against one another, 
there is minimal evidence of the comparative effectiveness of the different intervention 
components and parent and/or youth targets. Some of these comparisons were difficult to 
interpret because the trials varied dramatically on adolescent baseline depressive symptoms, 
income, and parent education. Also, this paper did not examine hypothesized mediators, 
intervention dosage, or outcomes beyond 2 years, given that only 5 of the 19 trials had 
longitudinal data beyond this time period. Finally, we note that all but two of the trials 
delivered at least part of their intervention in a group format. None of the trials included the 
group clustering identity in their datasets, nor did they account for clustering when 
analyzing their own trials, so we were unable to account for this clustering in our analyses. 
Potentially, such clustering could increase standard errors and reduce the level of 
significance of our findings.
Implications
There is still a lack of knowledge about exactly how much improvement we would expect in 
preventing depressive disorders at a population level with different prevention strategies. 
Much of our epidemiologic knowledge about adolescent depression is focused on treatment 
rather than prevention and we discuss this first. Epidemiologically, more that 9% of the 
adolescent population 12-18 years old experienced a major depressive episode within the 
past year (Substance Abuse and Mental Health Services Administration & Center for 
Behavioral Health Statistics and Quality, September 4, 2014). Current levels of treatment are 
inadequate. Among these youth who are experiencing a disorder, just one-third of those 
receive health care to treat their depression (Avenevoli, Swendsen, He, Burstein, & 
Merikangas, 2015). If we could guarantee that all such youth were provided the high quality 
treatment, antidepressants and/or CBT or IBT, we could expect about two-thirds of these 
individuals to have a substantial reduction in depressive symptoms (Brent et al., 1997; 
Gibbons, Hur, et al., 2012), compared to about a third of these experiencing a reduction in 
symptoms as a consequence of the natural episodicity of depression. Thus, under our current 
treatment system, we can expect well below 20% of the more than 2 million 12-18 year olds 
experiencing a major depressive episode to be provided an intervention that will ultimately 
improve their outcome. That leaves at least 1.6 million depressed youth without an effective 
treatment. Given the vast level of untreated adolescents with depression, prevention 
strategies can play a major role in addressing this unmet mental health need. Our analysis 
has shown that prevention is indeed effective in reducing depressive symptoms prior to the 
onset of a full depressive episode for those with subclinical symptoms, and while our trials 
did not afford the opportunity to assess averted depressive disorders, it is likely that they too 
were affected. Indeed, in this era of major health policy change to expand mental health 
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coverage for treatment and prevention, the prevention programs that we examined here may 
provide a fundamental first line of defense against a disorder that, if untreated, often has 
lifetime consequences on mental health (Thapar, Collishaw, Pine, & Thapar; Weisz, Sandler, 
Durlak, & Anton, 2005), physical health (Prince et al., 2007), and disability (Andrews, 
Sanderson, Corry, & Lapsley, 2000; Ferrari et al., 2013). A growing area of both research 
and service involves how to integrate effective behavioral health into primary care (Asarnow 
et al., 2005; Butler et al., 2008; Jaycox et al., 2006; Wells, Kataoka, & Asarnow, 2001), and 
we recommend that these efforts be expanded.
Attempts to prevent depression have ranged from universal interventions to highly targeted 
risk populations. Some but not all of these have been successful. Our analyses show that 
among those who have elevated, subclinical symptoms, the effects of prevention programs, 
particularly those directly targeting the child, have a strong and lasting impact. We believe 
the evidence of their impact is sufficiently strong to recommend their expanded use in 
diverse settings that until now have focused mostly on treatment for depression (e.g. primary 
care, children’s mental health, foster care, juvenile justice, schools) if at all. The preventive 
interventions described here provide a major opportunity to improve the nation’s mental 
health for the following reasons. First, the problem of youth depression is exceptionally 
high. Close to 10% of youth experience a major depressive disorder (MDD) in the United 
States each year (Substance Abuse and Mental Health Services Administration & Center for 
Behavioral Health Statistics and Quality, September 4, 2014), with 15% having a diagnosis 
of MDD before age 25, and an additional 10% experience a minor depressive disorder 
(Kessler & Walters, 1998). Second, symptoms of depression usually arise 2-3 or more years 
before a diagnosis of MDD occurs, and generally around age 12 (Institute of Medicine & 
National Research Council, 2009), thus providing an excellent opportunity to deliver 
effective prevention programs before first episode onset. Third, depression is an episodic 
disorder, with nearly ¾ reporting recurrence during childhood or young adulthood, with very 
few episodes lasting over two years (Kessler & Walters, 1998). This episodicity provides 
multiple opportunities to offer preventive interventions, which have been shown to have 
long-term effects for those who have experienced prior episodes. Finally, the major 
expansion of mental health services through the Mental Health Parity and Addictions 
Equality Act and the Patient Protection and Affordable Care Act (ACA) have now provided 
expanded mental health services for an estimated 62 million Americans (Frank, Beronio, & 
Glied, 2014), a substantial portion of whom are adolescents. The use of pediatrics and 
family medicine to deliver such programs seems very promising, although research is 
needed to test how these prevention programs can be most effectively delivered and financed 
within those settings. In particular, the current recommendations from the US Preventive 
Services Task Force to provide screenings and treatment for depression for those between 12 
and 18 years of age could usefully and readily be expanded to include prevention-focused 
interventions for subclinical levels of depression.
While some parenting interventions have shown longer-term impact on depression beyond 
two years, overall we did not observe an impact on depression, and thus their primary use is 
to prevent substance use, conduct disorder, violence, and sexual risk behavior (Leslie, 2016). 
Because the parenting interventions we included in this paper were primarily designed to 
prevent externalizing problems, substance use, or to promote adjustment to stressful 
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transitions, it may be that they did not focus on those aspects of parenting or family life that 
most impact the development of depression. Yap and Jorm (2015) in a meta-analytic study 
reported specific aspects of family functioning that are most strongly associated with 
depression and internalizing problems including high inter-parental conflict, parental over 
involvement, abusive parenting and low parental warmth. Parent-focused components in 
prevention programs may be quite appropriate in specific situations, particularly when 
parents themselves are undergoing a depressive episode (Brent et al., 2015; Garber et al., 
2009), and when low baseline levels of parent-child communication can be improved 
(Perrino et al., 2014). Family-focused intervention trials are underway to test whether 
changing these specific aspects of family life leads to prevention of youth depressive 
symptoms (Compas et al., 2009; Compas et al., 2011).
In addition, the current data found no diminishment of program effects for ethnic minorities 
compared to majority youth. This is important because ethnic and racial minority youth 
experience greater socioeconomic and educational disadvantage, important risk factors for 
the development of depression (Reiss, 2013; Yoshikawa, Aber, & Beardslee, 2012). 
Implementing preventive interventions in minority communities should be considered, 
particularly where there is limited access to, or use of, primary and mental healthcare and 
where mental disorder diagnosis is highly stigmatizing (Cummings & Druss, 2011).
In conclusion, this paper demonstrates that prevention programs have a robust and persistent 
beneficial effect on adolescents’ depressive symptoms, lasting up to two years. Youth who 
start with higher depressive symptoms (approaching but below clinical levels) and are given 
CBT or IPT interventions directly provide the best opportunity for long-term benefit.
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Refer to Web version on PubMed Central for supplementary material.
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Follow-Up Rates Across Time
Footnote:
Trial 18 is missing 49 participants at baseline.
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Functional Transformation of Time Used in Growth Modeling
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Depressive Symptoms across Time among Youth with High Symptoms at Baseline in 
Depression-Focused Trials and Among Youth with Low Symptoms at Baseline
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Distribution of Intervention Versus Control Effect from 24 Interventions in 19 Trials
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Table 1
Characteristics of the 19 Trials


































ADEPT 94 94 24 2 CBT P, C Depression Clarke AGP 2001
CATCH-IT 83 50 30 2 CBT,IPT P, C Depression
Van Voorhees et 
al., 2009
Family Talk 121 72 48 2 Family P, C,CJ Depression
Beardslee et al., 
2003
IPT-AST vs CBT 380 379 18 3 CBT,IPT C Depression
Horowitz et al., 
2007
K-IPT AST 57 57 18 3 IPT C, CJ Depression Young, Mufson, & Gallop 2010








408 407 24 3 CBT,Family P, C Depression





316 316 6 2 CBT P, C Depression Garber et al., 2009
Bridges (Puentes) 516 542 14 2 Family P, C,CJ Other
Gonzales et al., 
2012
Familias Unidas I 266 257 36 3 Family P, CJ Other Prado et al., 2007
Familias Unidas II 213 213 30 2 Family P, CJ Other Pantin et al., 2009
Familias Unidas DJJ 242 242 12 2 Family P, CJ Other Prado et al., 2011
Familias Unidas CDC n/a 160 12 2 Family P, CJ Other Not yet published
Family Bereavement 244 141 72 2 CBT,Family
P, C,
CJ Other
Sandler et al., 
2003
New Beginnings 240 99 72 3 CBT,Family
P, C,
CJ Other
Wolchik et al. 
2000
Preparing for the 
Drug





667 659 80 3 Family P, C,CJ Other
Spoth et al., 
1995;
Spoth et al., 2001
Project Alliance I 672(998) 178 72 2 Family C, CJ Other
Dishion et al., 
2002;
Connell et al., 
2007
Project Alliance II 593 581 60 2 Family P, C,CJ Other
Stormshak et al. 
2011
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Table 2
Baseline comparisons by Intervention Condition
Intervention Control Comparison
N 2868 2342 Score DF P
Age 12.74 (1.51) 12.97 (1.55)
5.32
† 5208 <0.001






  Hispanic (all races) 923 (32.2%) 780 (33.3%)
  Black, non-Hispanic 31 (1.1%) 24 (1.0%)
  White, non-Hispanic 124 (4.3%) 115 (4.9%)
  Asian, non-Hispanic 0 (0.0%) 2 (0.1%)
  Other/Multiple Race 6 (0.2%) 7 (0.3%)






  No high school 162 (5.6%) 134 (5.7%)
  Some high school 203 (7.1%) 179 (7.6%)
  High school/GED 536 (18.7%) 365 (15.6%)
  Some college 692 (24.1%) 389 (16.6%)
  College/higher degree 757 (26.4%) 421 (18.0%)
Measures
  RBPC-ANX/WIT 5.33 (5.42) 4.97 (4.91)
−1.00
†† 0.32
  YSR-ANX/DEP 5.12 (4.57) 4.95 (4.32)
−0.84
†† 0.4
  YSR-WIT/DEP 3.96 (2.86) 3.93 (2.74)
−0.13
†† 0.9
  CDRS-R 28.61 (8.35) 28.62 (7.98)
0.03
†† 0.98
  CESD 18.47 (10.25) 18.77 (11.19)
0.43
†† 0.67
  CDI 8.95 (7.59) 9.35 (7.82)
1.19
†† 0.23
  CBCL-ANX/DEP 3.98 (3.65) 3.85 (3.50)
−0.53
†† 0.59
  CBCL-WIT/DEP 2.86 (2.50) 2.79 (2.53)
−0.39
†† 0.69
  Single Factor Score* 0.002 (0.036) 0
(Reference)
0.95
Values reported as mean (standard deviation), n (%)
Additionally, measures are listed with abbreviated titles as described in the text.
*
beta coefficient (standard error).
†
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